Didn't find the right document?
Request a documentAEROSIL® 300 Pharma is colloidal silicon dioxide or silica obtained synthetically from silicon tetrachloride under high-temperature conditions. It is aimed at applications that require silica with a very high specific surface area, which is, in this case, approximately 300 m2/g.
AEROSIL® 300 Pharma is supplied as a white, light, fluffy and extremely fine powder. It is mainly used as an excipient, stabiliser and performance additive in topical pharmaceutical formulations.
Features
Approved for use in pharmaceuticals as an excipient
Synthetic material, of extremely high purity. Non-GMO, BSE-TSE- free and consistent physical properties
Can be used as a glidant for tablet, capsules and powder formulations
Excellent texturiser for oils and emulsions
Specific surface area 300 m2/g
Benefits
Absorbs/binds moisture, which can be advantageous in moisture-sensitive formulations
Small particle size and large specific surface area is advantageous as a flow aid for dry powders in tabletting and capsule filling
Improves tablet hardness during compaction
Excellent flow characteristics in powders
Can be used to make transparent gels
Applications
AEROSIL® 300 Pharma is widely used in topical pharmaceutical products as an emulsion stabilizer, suspending agent and viscosity-increasing agent
AEROSIL® 300 Pharma is also used as an adsorbent dispersing agent for liquids in powders
AEROSIL® 300 Pharma may be added to suppository formulations containing lipophilic excipients to increase viscosity, prevent sedimentation during moulding and decrease the release rate
Improves blending distribution of API's
Desiccant for moisture-sensitive actives
Glidant and anti-caking agent to improve powder properties